RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 84 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,000 | -35.5% | 4,000 | 0.0% | 0.00% | -25.0% |
| Q1 2024 | $18,600 | +12.3% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $16,560 | +38.0% | 4,000 | 0.0% | 0.00% | +33.3% |
| Q3 2023 | $12,000 | +22.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,840 | +172.1% | 4,000 | +150.0% | 0.00% | +200.0% |
| Q1 2023 | $3,616 | -35.2% | 1,600 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $5,584 | -90.5% | 1,600 | 0.0% | 0.00% | -88.9% |
| Q3 2022 | $59,000 | +96.7% | 1,600 | 0.0% | 0.02% | +100.0% |
| Q2 2022 | $30,000 | -30.2% | 1,600 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $43,000 | +19.4% | 1,600 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $36,000 | -14.3% | 1,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $42,000 | -17.6% | 1,600 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $51,000 | -8.9% | 1,600 | 0.0% | 0.01% | -6.7% |
| Q1 2021 | $56,000 | +9.8% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $51,000 | +8.5% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $47,000 | – | 1,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 2,837,818 | $9,903,985 | 0.42% |
| Sio Capital Management, LLC | 235,500 | $821,895 | 0.30% |
| Sio Capital Management, LLC | 235,600 | $822,244 | 0.30% |
| apricus wealth, LLC | 77,329 | $269,878 | 0.25% |
| RTW INVESTMENTS, LP | 2,067,824 | $7,216,706 | 0.15% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 496,254 | $1,731,926 | 0.14% |
| Aristides Capital LLC | 69,322 | $241,934 | 0.12% |
| XTX Topco Ltd | 129,387 | $451,561 | 0.10% |
| AdvisorShares Investments LLC | 81,362 | $283,953 | 0.08% |
| Ikarian Capital, LLC | 65,491 | $228,563 | 0.06% |